Compare abrdn Income Credit Strategies Fund (ACP) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
abrdn Income Credit Strategies Fund vs Nuwellis Inc — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $641.16M), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: abrdn Income Credit Strategies Fund is far larger — about 1181.2× Nuwellis Inc's market cap, and abrdn Income Credit Strategies Fund pays a 18.2% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| ACP | NUWE | |
|---|---|---|
Market Cap | $641.16M | $542.80K |
Sector | Financials | Technology |
52-Week High | $5.98 | $220.50 |
52-Week Low | $5.01 | $1.42 |
Dividend Yield | 18.2% | — |
Enterprise Value | — | -$1.27M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
